Back to top

Spero Therapeutics appoints Debra Jeske Zack as chief medical officer

Spero Therapeutics (SPRO) announced the appointment of Debra Jeske Zack as chief medical officer. Zack will lead Spero’s clinical development strat...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Spero Therapeutics, Inc. (SPRO)

Exagen Inc. (XGN)